
About Pharmacheck Impex Private Limited
Data last updated:
Pharmacheck Impex Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2016PTC285203. Its GSTIN is 27AAICP7486L2ZJ (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹40.96 Lakh. It is led by directors Mohan Sudhakar Kale and Andrew James Strempler.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.101 Hyatt Enclave Congress Nagar Dhantoli, Nagpur, Maharashtra, India – 440012.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.87 Cr, a growth of 63% compared to the previous year. For the same year it recorded a net profit of ₹7 Cr (net margin 41.5%) and EBITDA of ₹7.05 Cr (EBITDA margin 41.8%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 60% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmacheck.com.
Company details
Contact details
Pharmacheck Impex Private Limited's registered office is in Nagpur, Maharashtra. Its website is pharmacheck.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No.101 Hyatt Enclave Congress Nagar Dhantoli, Nagpur, Maharashtra, India – 440012
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Pharmacheck Impex Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pharmacheck Impex is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pharmacheck Impex Private Limited, buy the company report.
Financials of Pharmacheck Impex Private Limited
FY 2025 filings availablePharmacheck Impex Private Limited reported revenue of ₹16.87 Cr (up 63% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 60% over five years, including 63% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.8% | ||||
| Net Profit Margin | 41.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmacheck Impex Private Limited, buy the company report.
Board of directors of Pharmacheck Impex Private Limited
Pharmacheck Impex has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohan Sudhakar Kale Also directs: Nagpur Naturals Farmer Producer Company Limited, Wasudha Smriti (OPC) Private Limited, DND Enterprises Private Limited and 2 more | Director | 26 Aug 2016 | 10 Years 2 Months | Current |
| Andrew James Strempler | Director | 26 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Pharmacheck Impex Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shri Imaging and X-Ray Films Private Limited | ₹17 Cr (FY 2025) | -11.0% | Chandigarh, India | |||
| Olympus Therapeutics Private Limited | ₹16.9 Cr (FY 2025) | 3.0% | Chennai, Tamil Nadu, India | |||
| Starlex Health Services and Products Private Limited | ₹16.89 Cr (FY 2025) | -3.0% | Perinthalmanna, Kerala, India | |||
| Pharmacheck Impex Private Limitedthis company | ₹16.87 Cr (FY 2025) | ₹7 Cr | 41.5% | 63.0% | 12 | Nagpur, Maharashtra, India |
| Mahaswaan Pharma Private Limited | ₹16.83 Cr (FY 2024) | -35.0% | New Delhi, Delhi, India | |||
| Medicine Distributors Private Limited | ₹16.77 Cr (FY 2024) | 17.0% | Uttar Pradesh, India |
To see the full peer comparison of Pharmacheck Impex Private Limited, buy the company report.
Auditor
Pharmacheck Impex Private Limited is audited by KAKDE & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAKDE & ASSOCIATES | FY 2023 | 157358W |
Shareholding
The shareholding of Pharmacheck Impex Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharmacheck Impex Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmacheck Impex Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmacheck Impex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pharmacheck Impex Private Limited has a workforce of 12 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 12 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Pharmacheck Impex Private Limited, buy the company report.
GST
Pharmacheck Impex has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICP7486L2ZJ | Maharashtra | Active | 01 Aug 2017 |
To see the full GST registrations and return filing status of Pharmacheck Impex Private Limited, buy the company report.
Recent activity
Pharmacheck Impex Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Andrew James Strempler was appointed as Director on 26 Aug 2016.
Frequently asked questions
Pharmacheck Impex is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 August 2016 (10+ years old) and is registered under CIN U24239MH2016PTC285203.
Pharmacheck Impex has 2 current directors:
- Mohan Sudhakar Kale - Director
- Andrew James Strempler - Director
The latest financial statements of Pharmacheck Impex on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Pharmacheck Impex is 27AAICP7486L2ZJ, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Pharmacheck Impex is U24239MH2016PTC285203. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmacheck Impex was incorporated on 26 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pharmacheck Impex by revenue are Shri Imaging and X-Ray Films Private Limited, Olympus Therapeutics Private Limited, Starlex Health Services and Products Private Limited, Mahaswaan Pharma Private Limited, Medicine Distributors Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Andrew James Strempler was appointed as Director on 26 Aug 2016. Mohan Sudhakar Kale was appointed as Director on 26 Aug 2016.
Pharmacheck Impex can be reached through the website pharmacheck.com. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Pharmacheck Impex is at Shop No.101 Hyatt Enclave Congress Nagar Dhantoli, Nagpur, Maharashtra, India – 440012.
Pharmacheck Impex operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

